PluroGel vs Standard Dressing for Burns
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether PluroGel, an antimicrobial burn and wound dressing, is more effective than standard dressings for treating burn injuries. Researchers aim to determine if PluroGel can heal burns faster and with less pain than traditional methods, potentially reducing the need for surgery. The trial includes individuals with partial thickness burns on the face or a single limb who have been admitted to the hospital. Participants must not have burns covering more than 30% of their body or burns that are very deep initially. As a Phase 1, Phase 2 trial, this research focuses on understanding how PluroGel works in people and measuring its effectiveness in a smaller group, offering participants a chance to be among the first to benefit from this innovative treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that PluroGel is generally safe and well-tolerated. This water-based dressing helps keep wounds moist, supporting healing. Studies indicate it is safe for use on various burns, including first and second-degree burns. PluroGel is also used for other types of wounds, which suggests a good safety record. Although specific reports of negative effects are absent in the sources, its use for different wounds and burns suggests it is likely safe for people.12345
Why do researchers think this study treatment might be promising?
PluroGel is unique because it combines a hydrophilic gel with a standard dressing to enhance healing for burn wounds. Unlike typical burn treatments that often rely solely on topical antibiotics and non-adherent dressings, PluroGel's hydrophilic nature helps keep the wound environment moist, which can accelerate healing. Researchers are excited about its potential to reduce infection and improve recovery times, offering a more effective alternative to traditional burn care options.
What evidence suggests that PluroGel could be an effective treatment for burns?
Research has shown that PluroGel, which participants in this trial may receive, may aid in treating burns by maintaining wound moisture. This supports healing and naturally breaks down dead tissue. One study found that PluroGel improved healing in leg ulcers, suggesting potential benefits for burn wounds as well. Additionally, PluroGel stabilizes the wound, which is crucial for preventing complications. Although data specifically on burns is limited, positive results in general wound healing make it a promising option. PluroGel's ability to hydrate and protect the wound is a key factor in its potential effectiveness. Meanwhile, the standard dressing, another treatment option in this trial, involves applying topical antibiotic ointment and non-adherent petrolatum fine-meshed gauze regularly.26789
Are You a Good Fit for This Trial?
This trial is for individuals with partial thickness burns on the face or one limb that require hospital admission. It's not suitable for those with full-thickness burns, electrical or chemical burns, malnutrition, previous excisions elsewhere, or if more than 30% of their body is burned.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either PluroGel® or standard topical dressing for burn injuries
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PluroGel
- Standard dressing
PluroGel is already approved in United States for the following indications:
- Management of full and partial thickness wounds including surgically created wounds, dermal ulcers (pressure ulcers), leg ulcers (diabetic foot ulcers), superficial wounds, first degree burns, partial thickness burns, and donor sites.
- Minor cuts, minor burns, and minor lacerations (OTC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor
Medline Industries
Industry Sponsor